Company profile
Raphael Pharmaceutical Inc. CIK 1415397
Ticker
RAPH (OTC)
Industry
Medicinal Chemicals & Botanical Products
Headquarters
Las Vegas, NV 89108
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$1.28M
Total assets
$53.0K
Total liabilities
—
Stockholders' equity
-$1.43M
Cash & equivalents
$45.0K
Operating income
-$1.25M
Operating cash flow
-$210.0K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
-2,703.8%
CapEx / revenue
—
Operating cash flow / net income
0.16×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$1.28M
$53.0K
—
-$1.43M
2024
—
-$1.52M
$27.0K
—
-$742.0K
2023
—
-$1.34M
$239.0K
—
$107.0K
2022
—
-$3.36M
$333.0K
—
$106.0K
2021
—
-$1.63M
$422.0K
—
$128.0K
Company Details
SIC code
2833
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-01
Financials filed via
Form 10-K
filed 2026-03-31
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Las Vegas, NV 89108
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:38 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.